0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
The vaccine was administered in a woman, who experienced neurological symptoms which is a rare but serious spinal inflammatory disorder called transverse myelitis, CEO Pascal Soriot, AstraZeneca said.
Share this article
If you liked this article share it with your friends.they will thank you later